[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0308347A - Processo para fabricação de piperazinas 1,4-dissubstituìdas quirais - Google Patents

Processo para fabricação de piperazinas 1,4-dissubstituìdas quirais

Info

Publication number
BR0308347A
BR0308347A BR0308347-0A BR0308347A BR0308347A BR 0308347 A BR0308347 A BR 0308347A BR 0308347 A BR0308347 A BR 0308347A BR 0308347 A BR0308347 A BR 0308347A
Authority
BR
Brazil
Prior art keywords
chiral
piperazines
disubstituted piperazines
manufacture
disubstituted
Prior art date
Application number
BR0308347-0A
Other languages
English (en)
Inventor
Ivo Jirkovsky
Joseph Zeldis
Gregg Brian Feigelson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0308347A publication Critical patent/BR0308347A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/06—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing halogen atoms, or nitro or nitroso groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA FABRICAçãO DE PIPERAZINAS 1,4-DISSUBSTITUìDAS QUIRAIS". A presente invenção refere-se a um processo para a preparação estéreosseletiva de novos derivados mostarda de nitrogênio quirais úteis em síntese de piperazinas 1,4-dissubstituídas oticamente ativas de fórmula (I) onde R, Ar, e Q são definidos como aqui mostrado, e compostos intermediários para as mesmas. As piperazinas 1,4-dissubstituídas atuam como agentes de ligação de receptor de 5HT1A úteis no tratamento de distúrbios do Sistema Nervoso Central (CNS).
BR0308347-0A 2002-03-12 2003-03-10 Processo para fabricação de piperazinas 1,4-dissubstituìdas quirais BR0308347A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36345802P 2002-03-12 2002-03-12
PCT/US2003/007176 WO2003078420A2 (en) 2002-03-12 2003-03-10 Process for making chiral 1,4-disubstituted piperazines

Publications (1)

Publication Number Publication Date
BR0308347A true BR0308347A (pt) 2005-01-25

Family

ID=28041772

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308347-0A BR0308347A (pt) 2002-03-12 2003-03-10 Processo para fabricação de piperazinas 1,4-dissubstituìdas quirais

Country Status (20)

Country Link
US (3) US7019137B2 (pt)
EP (1) EP1483256A2 (pt)
JP (1) JP2005527530A (pt)
KR (1) KR20040091119A (pt)
CN (2) CN100451014C (pt)
AR (1) AR038931A1 (pt)
AU (1) AU2003220110B2 (pt)
BR (1) BR0308347A (pt)
CA (1) CA2477906A1 (pt)
CR (1) CR7428A (pt)
EC (1) ECSP045292A (pt)
IL (1) IL163828A0 (pt)
MX (1) MXPA04008730A (pt)
NO (1) NO20043988L (pt)
NZ (1) NZ535169A (pt)
RU (2) RU2315044C2 (pt)
TW (1) TW200304825A (pt)
UA (1) UA79774C2 (pt)
WO (1) WO2003078420A2 (pt)
ZA (1) ZA200408205B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1408976T5 (da) 2001-07-20 2011-01-10 Psychogenics Inc Behandling af ADHD (Attention deficit hyperactivity disorder)
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
NZ535169A (en) * 2002-03-12 2006-03-31 Wyeth Corp Process for making chiral 1,4-disubstituted piperazines
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
EP2896624B1 (en) 2007-03-28 2016-07-13 Atir Holding S.A. Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
CN108627380B (zh) * 2017-03-15 2020-10-20 中国人民解放军军事医学科学院毒物药物研究所 去除或减少有毒物质的方法以及检测有毒物质的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE960203C (de) * 1953-12-25 1957-03-21 Yoshitomi Pharmaceutical Verfahren zur Herstellung von N-substituierten Aminocarbonsaeureestern
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
MX9201991A (es) 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
WO1993021186A1 (en) * 1992-04-13 1993-10-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds
WO1994024115A1 (en) 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Novel piperazine derivative
IL113966A (en) 1994-06-03 2000-08-13 Wyeth John & Brother Ltd Process for the preparation of piperazine derivatives cyclic amides of N-heteroaryl-aminoalkoxysulphonic acids and of N-heteroaryl-aminoalkoxysulphenic acids as intermediates therefor and process for their preparation
GB9411099D0 (en) 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9413772D0 (en) 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
EP0775118B1 (en) * 1994-08-05 2003-06-04 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
GB9514901D0 (en) 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
CA2251017A1 (en) 1996-04-10 1997-10-16 Mark E. Duggan .alpha.v.beta.3 antagonists
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
JPH11106381A (ja) * 1997-09-30 1999-04-20 Ss Pharmaceut Co Ltd クロメン誘導体及びその塩並びにこれを含有する医薬
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents
MXPA04005158A (es) * 2001-11-30 2004-08-11 Schering Corp Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol.
NZ535169A (en) * 2002-03-12 2006-03-31 Wyeth Corp Process for making chiral 1,4-disubstituted piperazines
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
CN1304388C (zh) * 2002-03-12 2007-03-14 惠氏公司 合成手性n－芳基哌嗪的方法
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
MXPA04008731A (es) 2002-03-12 2004-12-06 Wyeth Corp Preparacion de acido n1-(2¦-piridil)-1,2-propanodiamino sulfamico y su uso en la sintesis de piperazinas biologicamente activas.

Also Published As

Publication number Publication date
AU2003220110B2 (en) 2009-04-09
NO20043988L (no) 2004-09-23
US7256289B2 (en) 2007-08-14
WO2003078420A2 (en) 2003-09-25
RU2315044C2 (ru) 2008-01-20
US7019137B2 (en) 2006-03-28
ECSP045292A (es) 2004-10-26
ZA200408205B (en) 2007-03-28
RU2004130313A (ru) 2005-04-10
CN101492383A (zh) 2009-07-29
EP1483256A2 (en) 2004-12-08
TW200304825A (en) 2003-10-16
US20050228181A1 (en) 2005-10-13
NZ535169A (en) 2006-03-31
KR20040091119A (ko) 2004-10-27
JP2005527530A (ja) 2005-09-15
WO2003078420A3 (en) 2004-03-11
AR038931A1 (es) 2005-02-02
UA79774C2 (en) 2007-07-25
US20080058543A1 (en) 2008-03-06
AU2003220110A1 (en) 2003-09-29
CR7428A (es) 2008-09-23
CA2477906A1 (en) 2003-09-25
CN1642937A (zh) 2005-07-20
RU2007125687A (ru) 2009-01-20
IL163828A0 (en) 2005-12-18
US20030208075A1 (en) 2003-11-06
CN100451014C (zh) 2009-01-14
MXPA04008730A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
ATE449082T1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
BR0316375A (pt) Diazinopirimidinas
TW200420569A (en) New ruthenium complexes as (pre)catalysts for the metathesis reaction, 2-alkoxy-5-nitrostyrene derivatives as intermediates and the method of their manufacturing
HK1101178A1 (en) Alkynyl derivatives as modulators of metabotropic glutamate receptors
WO2006132914A3 (en) Cyclobutyl amine derivatives
DE60235396D1 (de) 3-amido-1,2-benzisoxazolderivate, herstellungsverfahren und deren verwendung
BR0308347A (pt) Processo para fabricação de piperazinas 1,4-dissubstituìdas quirais
PT1265888E (pt) Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios
DE50306111D1 (de) Hydroxydiphosphine und deren verwendung in der katalyse
NO20076000L (no) Aminosyrederivater
DK1720823T3 (da) Ny fremgangsmåde til syntese af substituerede alpha-amino-indanderivater
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
BR0012631A (pt) Processo para a preparação de compostos de amina
BR0210410A (pt) Processo para produção do derivado de piperidina, fexofenadina
DE60200135D1 (de) 4-(2-Pyridyl)piperazine als Agonisten des 5HT7 Rezeptors
BRPI0409095A (pt) processos de sìntese do ácido (2s)-indolina-2-carboxìlico, e aplicação para a sìntese do perindopril
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
ATE500286T1 (de) Synthese von acylharnstoffen und acylharnstoffe enthaltende zusammensetzung
WO2004013082A3 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
BR0112998A (pt) Derivados de indol úteis para o tratamento de distúrbios do sistema nervoso central (snc); composto; sua utilização; composição farmacêutica e método de tratamento
UA74426C2 (uk) Фенілпіперазини
DE602006007682D1 (de) 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen
BR0316392A (pt) Processo para preparar ácido indan-1,3-dicarboxìlico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.